PRED MILD prednisolone acetate suspension/ drops Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

pred mild prednisolone acetate suspension/ drops

preferred pharmaceuticals, inc - prednisolone acetate (unii: 8b2807733d) (prednisolone - unii:9phq9y1olm) - prednisolone acetate 1.2 mg in 1 ml

PRED-G- gentamicin, prednisolone acetate suspension/ drops Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

pred-g- gentamicin, prednisolone acetate suspension/ drops

allergan, inc. - gentamicin (unii: t6z9v48ikg) (gentamicin - unii:t6z9v48ikg), prednisolone acetate (unii: 8b2807733d) (prednisolone - unii:9phq9y1olm) - gentamicin 3 mg in 1 ml - pred-g ® suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aur

AZARGA brinzolamide 1% and timolol 0.5% eye drops. Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

azarga brinzolamide 1% and timolol 0.5% eye drops.

novartis pharmaceuticals australia pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); brinzolamide, quantity: 10 mg/ml - eye drops - excipient ingredients: hydrochloric acid; benzalkonium chloride; sodium chloride; tyloxapol; carbomer 974p; mannitol; sodium hydroxide; disodium edetate; purified water - decrease of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension for whom monotherapy with either component provides insufficient iop reduction.

LATANOCOM latanoprost 50 microgram/mL, timolol (as maleate) 5 mg/mL eye drops Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

latanocom latanoprost 50 microgram/ml, timolol (as maleate) 5 mg/ml eye drops

aspen pharmacare australia pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; benzalkonium chloride; dibasic sodium phosphate; water for injections; sodium chloride; hydrochloric acid; monobasic sodium phosphate monohydrate - the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanocom should not be used to initiate therapy.